Clinical Trial Update: R-2487 in Patients With Sjogren's Syndrome (SS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for R-2487 in Sjögren's syndrome, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• R-2487

Snippet

Sponsor: Rise Therapeutics LLC | Conditions: Sjogren's Syndrome, Sjögren | Phase 1 | Status: NOT_YET_RECRUITING